We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 593

EU Court of Justice Advocate General issues ruling on Stem Cell patentability

  • Shook Hardy & Bacon LLP
  • -
  • European Union, United Kingdom
  • -
  • August 7 2014

In a non-binding ruling, Advocate General Cruz Villalón of the EU Court of Justice has determined that unfertilized human ova whose division

Joint public meeting to focus on bridging nanotechnology research

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • February 24 2011

The National Nanotechnology Coordination Office has announced that it will spearhead a public meeting to focus on "environmental health and safety questions for nanomaterials and nanotechnology-enabled products" and to "encourage joint US-EU programs of work that would leverage resources."

Distributor enters guilty plea for unapproved development and sale of stem cells

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 1 2011

An Arizona woman who formerly owned a company that sold stem cells to clinics to treat patients with incurable autoimmune diseases, such as amyotrophic lateral sclerosis and multiple sclerosis, has entered a guilty plea to charges that she did so without meeting Food and Drug Administration (FDA) requirements

IOM publishes report on the effects of falsified and substandard medicines

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • February 21 2013

At the request of the U.S. Food and Drug Administration (FDA), national think tank the Institute of Medicine (IOM) has published a report that

Research institution creates regional biomedical hub in Florida

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 10 2011

The Jackson Laboratory, a Maine-based biomedical research institution, has announced a partnership to develop "genetics-based" treatments for heart disease, Alzheimer's disease and diabetes at a new 120,000-square-foot research facility in Sarasota County, Florida

India holds out among countries requiring transparency in industry payments

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • June 20 2013

According to a news source, while many countries have instituted disclosure obligations on health-care companies, often pharmaceutical and

Patentability of medical treatment claims to be heard by U.S. Supreme Court

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 30 2011

The U.S. Supreme Court has agreed to review a Federal Circuit Court of Appeals ruling that methods for determining the optimal dosage of thiopurine drugs used to treat gastrointestinal and non-gastrointestinal autoimmune diseases recite patentable subject matter under 35 U.S.C. 101

Federal Court allows FDA to exercise authority over stem cells

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 2 2012

A federal court in the District of Columbia has determined that “the cultured cell product is a drug within the meaning of the Federal Food, Drug, and Cosmetic Act” and “a biological product within the meaning of 42 U.S.C. 262,” and imposed a permanent injunction against a company and several individuals who allegedly manufactured and distributed misbranded and adulterated stem cells

Fractured Myriad Genetics ruling follows SCOTUS remand

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 30 2012

Ruling that one plaintiff had standing to seek a declaratory judgment as to the patent eligibility of certain genetic discoveries, the Federal Circuit Court of Appeals has once again reversed in part and affirmed in part a lower court’s determination that isolated DNA molecules and methods of comparing molecules to determine whether a patient’s genes have mutations that could cause breast and ovarian cancer were not patent eligible

Advocacy coalition agrees to drop nanotechnology lawsuit against FDA

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

A coalition of advocacy organizations has reportedly agreed to dismiss as moot its lawsuit seeking an order requiring the Food and Drug Administration (FDA) to respond to its 2006 petition asking the agency to regulate products containing nanomaterials